


|
|
|
Insider Transactions
| Date |
Name |
Title |
Type |
Shares Traded |
Price Range |
| Jan 9, 2012 |
Green, David |
Officer |
Disposition (Non Open Market) |
20,602 |
3.87 |
| Jan 9, 2012 |
luscinski susan m |
Officer |
Disposition (Non Open Market) |
7,656 |
3.87 |
| Jun 2, 2011 |
graziano chane |
Officer |
Acquisition (Non Open Market) |
53,750 |
n/a |
| Jun 2, 2011 |
Green, David |
Officer |
Acquisition (Non Open Market) |
53,750 |
n/a |
| Jun 2, 2011 |
luscinski susan m |
Officer |
Acquisition (Non Open Market) |
18,750 |
n/a |
| Jun 2, 2011 |
mcnaughton thomas |
Officer |
Acquisition (Non Open Market) |
25,000 |
n/a |
| Apr 26, 2011 |
Green, David |
Officer |
Automatic Sell |
2,944 |
5.97 |
| Apr 25, 2011 |
Green, David |
Officer |
Automatic Sell |
11,556 |
5.96 |
| Apr 5, 2011 |
Green, David |
Officer |
Automatic Sell |
6,000 |
6.04 |
| Apr 4, 2011 |
Green, David |
Officer |
Automatic Sell |
1,000 |
5.95 |
| Mar 31, 2011 |
Green, David |
Officer |
Automatic Sell |
400 |
5.96 |
| Mar 30, 2011 |
Green, David |
Officer |
Automatic Sell |
37,300 |
6.08 |
| Mar 29, 2011 |
Green, David |
Officer |
Automatic Sell |
40,800 |
6.01 |
| Jan 25, 2011 |
graziano chane |
Officer |
Disposition (Non Open Market) |
11,353 |
4.08 |
| Jan 25, 2011 |
Green, David |
Officer |
Disposition (Non Open Market) |
11,409 |
4.08 |
| Jan 25, 2011 |
luscinski susan m |
Officer |
Disposition (Non Open Market) |
5,991 |
4.08 |
| Jan 25, 2011 |
mcnaughton thomas |
Officer |
Disposition (Non Open Market) |
5,990 |
4.08 |
| Sep 16, 2010 |
graziano chane |
Officer |
Buy |
10,005 |
3.63 |
| Sep 15, 2010 |
graziano chane |
Officer |
Buy |
62,361 |
3.60 |
| Sep 14, 2010 |
graziano chane |
Officer |
Buy |
21,434 |
3.55 |
|
|
Stock transaction information provided by EDGAR Online. Harvard Bioscience, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.
|
|
|